Inhaled corticosteroids for COPD decrease mortality risk from pneumonia and other causes

Treatment of COPD with inhaled corticosteroids (ICS) may decrease the risk of dying from pneumonia and from other causes despite being associated with an increase in the occurrence of pneumonia, according to a new meta-analysis.